Skip to main content

People in the News: Feb 24, 2009

Premium

Aushon Biosystems has hired Mark Schmeizl to be vice president of North American sales. Schmeizl previously was a senior sales and marketing executive at PerkinElmer, Cisbio, and Affymetrix.


David Sneider has been named chief financial officer at Nerites. He joined the Madison, Wis.-based biotech from NimbleGen. He also previously served as CFO of Third Wave Technologies.


David Cox has joined Pfizer at chief scientific officer of its target generation unit. Cox was a co-founder of Perlegen, and he served as CSO at the company since 2000. He was a genetics and pediatrics professor at Stanford University School of Medicine, and he was a co-director of the Stanford Genome Center.


Joshua LaBaer has joined the Biodesign Institute at Arizona State University to serve as director of the new Virginia G. Piper Center for Personalized Diagnostics. LaBaer was most recently director of the Harvard Institute of Proteomics.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.